CervoMed Inc. SEC filings CRVO

CervoMed Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Oct 15, 1998. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

CervoMed Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 6, 2026 Sep 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 29, 2026 Oct 29, 2026
4 Insider transaction Oct 23, 2026 Oct 22, 2026
4 Insider transaction Oct 23, 2026 Oct 22, 2026
4 Insider transaction Oct 23, 2026 Oct 22, 2026
8-K Current report
Regulation FD disclosure
Oct 14, 2026 Oct 14, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 13, 2026 Oct 12, 2026
8-K Current report
Regulation FD disclosure
Oct 9, 2026 Oct 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 28, 2026 Sep 28, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 10, 2026 Sep 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
S-8 Employee stock plan registration Aug 7, 2026 —
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 4, 2026 Aug 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 14, 2026 Jul 14, 2026
EFFECT Filing Jul 10, 2026 —
424B3 Prospectus Jul 10, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2026 Jul 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 8, 2026 —
S-3 Shelf registration Jul 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 26, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 22, 2026 Jun 22, 2026
424B5 Prospectus supplement Jun 22, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 22, 2026 Jun 18, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 16, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 15, 2026 —
4 Insider transaction Jun 15, 2026 Jun 11, 2026
8-K Current report
Regulation FD disclosure
Jun 15, 2026 Jun 15, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jun 10, 2026 Jun 9, 2026
8-K Current report
Shareholder vote results
Jun 9, 2026 Jun 8, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 18, 2026 May 18, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 11, 2026 —
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Jun 8, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 22, 2026 Apr 22, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 7, 2026 —
8-K Current report
Regulation FD disclosure
Apr 7, 2026 Apr 7, 2026
8-K Current report
Regulation FD disclosure
Mar 23, 2026 Mar 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 19, 2026 Mar 19, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Mar 17, 2026 Mar 17, 2026
10-K Annual report Mar 13, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 4, 2026 Mar 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Feb 18, 2026 Feb 18, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2026 —
8-K Current report
Regulation FD disclosure
Jan 8, 2026 Jan 7, 2026
4 Insider transaction Dec 5, 2025 Oct 27, 2025
3 Initial insider ownership Dec 5, 2025 Oct 27, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 5, 2025 Dec 1, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 17, 2025 Nov 14, 2025
4 Insider transaction Nov 13, 2025 Nov 12, 2025
4 Insider transaction Nov 13, 2025 Nov 12, 2025
4 Insider transaction Nov 13, 2025 Nov 12, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
S-8 Employee stock plan registration Nov 7, 2025 —
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 4, 2025 Nov 4, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 29, 2025 Oct 27, 2025
8-K Current report
Regulation FD disclosure
Oct 22, 2025 Oct 22, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 8, 2025 Oct 8, 2025
4 Insider transaction Oct 8, 2025 Oct 6, 2025
3 Initial insider ownership Oct 8, 2025 Oct 6, 2025
UPLOAD Letter from the SEC Sep 24, 2025 —
CORRESP Letter to the SEC Sep 23, 2025 —
UPLOAD Letter from the SEC Sep 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Aug 5, 2025 Aug 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 28, 2025 Jul 28, 2025
8-K Current report
Shareholder vote results
Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
3 Initial insider ownership May 23, 2025 May 1, 2025
8-K Current report
Regulation FD disclosure
May 19, 2025 May 19, 2025
4 Insider transaction May 14, 2025 May 14, 2025
424B5 Prospectus supplement May 12, 2025 —
8-K Current report
Material agreement, Results of operations
May 12, 2025 May 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
SCHEDULE 13G Ownership over 5% (passive) May 7, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 29, 2025 Jun 23, 2025
8-K Current report
Material agreement, Agreement ended, Officer or director change
Apr 18, 2025 Apr 14, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 7, 2025 Apr 2, 2025
8-K Current report
Results of operations
Mar 18, 2025 Mar 17, 2025
S-8 Employee stock plan registration Mar 17, 2025 —
10-K Annual report Mar 17, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Mar 11, 2025 Mar 11, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 10, 2025 Mar 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 14, 2025 Feb 4, 2025
4 Insider transaction Feb 14, 2025 Feb 4, 2025
4 Insider transaction Feb 14, 2025 Feb 4, 2025
4 Insider transaction Feb 14, 2025 Feb 4, 2025
4 Insider transaction Feb 14, 2025 Feb 4, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 31, 2025 Jan 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 13, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 10, 2024 Dec 10, 2024
8-K Current report
Regulation FD disclosure
Dec 3, 2024 Dec 3, 2024
8-K Current report
Other events
Nov 27, 2024 Nov 27, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations, Other events
Nov 13, 2024 Nov 8, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Other events
Nov 4, 2024 Nov 4, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 30, 2024 Oct 29, 2024
8-K Current report
Other events
Oct 16, 2024 Oct 15, 2024
424B3 Prospectus Oct 11, 2024 —
EFFECT Filing Oct 10, 2024 —
424B3 Prospectus Oct 10, 2024 —
EFFECT Filing Oct 9, 2024 —
CORRESP Letter to the SEC Oct 8, 2024 —
UPLOAD Letter from the SEC Oct 8, 2024 —
S-3 Shelf registration Oct 3, 2024 —
POS AM Form pos am Oct 3, 2024 —
8-K Current report
Agreement ended
Oct 3, 2024 Oct 1, 2024
424B3 Prospectus Oct 1, 2024 —
8-K Current report
Other events
Oct 1, 2024 Sep 26, 2024
4 Insider transaction Aug 27, 2024 Aug 27, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 15, 2024 Aug 12, 2024
S-8 Employee stock plan registration Aug 9, 2024 —
424B3 Prospectus Aug 9, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
424B3 Prospectus Aug 1, 2024 —
8-K Current report
Other events
Aug 1, 2024 Jul 29, 2024
8-K Current report
Regulation FD disclosure
Jul 23, 2024 Jul 23, 2024
424B3 Prospectus Jul 12, 2024 —
8-K Current report
Other events
Jul 12, 2024 Jul 11, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
424B3 Prospectus Jun 14, 2024 —
8-K Current report
Shareholder vote results, Other events
Jun 14, 2024 Jun 11, 2024
424B3 Prospectus Jun 6, 2024 —
EFFECT Filing Jun 5, 2024 —
CORRESP Letter to the SEC Jun 3, 2024 —
S-1/A Amended registration statement May 30, 2024 —
8-K Current report
Material agreement, Agreement ended, Officer or director change, Other events
May 20, 2024 May 17, 2024
UPLOAD Letter from the SEC May 16, 2024 —
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
S-1 Registration statement May 10, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 14, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 23, 2024 Apr 22, 2024
SC 13G Ownership over 5% (passive) Apr 11, 2024 —
8-K Current report
Results of operations
Apr 5, 2024 Apr 1, 2024
8-K Current report
Regulation FD disclosure
Apr 4, 2024 Apr 4, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 28, 2024 Mar 28, 2024
8-K Current report Mar 18, 2024 Mar 12, 2024
SC 13G/A Amended ownership over 5% (passive) Mar 6, 2024 —
8-K Current report
Regulation FD disclosure
Mar 5, 2024 Mar 5, 2024
SC 13D/A Amended ownership over 5% (active) Feb 28, 2024 —
4 Insider transaction Feb 28, 2024 Feb 26, 2024
8-K Current report
Material agreement, Change to shareholder rights, Other events
Feb 28, 2024 Feb 26, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Feb 13, 2024 Feb 12, 2024
SC 13D Ownership over 5% (active) Feb 9, 2024 —
3 Initial insider ownership Feb 9, 2024 Feb 7, 2024
8-K Current report
Officer or director change, Other events
Feb 7, 2024 Feb 5, 2024
8-K Current report
Material agreement, Officer or director change
Feb 2, 2024 Feb 1, 2024
4 Insider transaction Jan 26, 2024 Jan 26, 2024
4 Insider transaction Jan 26, 2024 Jan 26, 2024
4 Insider transaction Jan 26, 2024 Jan 26, 2024
4 Insider transaction Jan 26, 2024 Jan 26, 2024
4 Insider transaction Jan 26, 2024 Jan 26, 2024
4 Insider transaction Jan 26, 2024 Jan 26, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CRVO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1053691
Former names
Diffusion Pharmaceuticals Inc. (until Aug 14, 2023); RestorGenex Corp (until Jan 14, 2016); Stratus Media Group, Inc (until Mar 7, 2014); FERIS INTERNATIONAL, INC. (until Jul 16, 2008); TITAN MOTORCYCLE CO OF AMERICA INC (until Feb 22, 2008)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.